Alisi A, Cho WC, Locatelli F et al (2013) Multidrug resistance and cancer stem cells in neuroblastoma and hepatoblastoma. Int J Mol Sci 14:24706–24725

Article  PubMed  PubMed Central  Google Scholar 

Alqarni MH, Foudah AI, Muharram MM et al (2022) Myricetin as a potential adjuvant in chemotherapy: studies on the inhibition of human glutathione transferase A1–1. Biomolecules 12:1364

Article  PubMed  PubMed Central  CAS  Google Scholar 

Amawi H, Sim HM, Tiwari AK et al (2019) ABC Transporter-mediated multidrug-resistant cancer. Adv Exp Med Biol 1141:549–580

Article  PubMed  CAS  Google Scholar 

Anderson NR, Sheth V, Li H et al (2023) Microenvironmental CXCL12 deletion enhances Flt3-ITD acute myeloid leukemia stem cell response to therapy by reducing p38 MAPK signaling. Leukemia 37:560–570

Article  PubMed  CAS  Google Scholar 

Bae KH, Lai F, Oruc B et al (2022) Self-assembled daunorubicin/epigallocatechin gallate nanocomplex for synergistic reversal of chemoresistance in leukemia. Int J Mol Sci 24:381

Article  PubMed  PubMed Central  Google Scholar 

Bai H, Xu R, Cao Z et al (2011) Involvement of miR-21 in resistance to daunorubicin by regulating PTEN expression in the leukaemia K562 cell line. FEBS Lett 585:402–408

Article  PubMed  CAS  Google Scholar 

Biondi M, Tettamanti S, Galimberti S et al (2023) Selective homing of CAR-CIK cells to the bone marrow niche enhances control of the acute myeloid leukemia burden. Blood 141:2587–2598

PubMed  PubMed Central  CAS  Google Scholar 

Brunel AS, Wójtowicz A, Lamoth F et al (2018) Pentraxin-3 polymorphisms and invasive mold infections in acute leukemia patients receiving intensive chemotherapy. Haematologica 103:e527–e530

Article  PubMed  PubMed Central  CAS  Google Scholar 

Chiou JT, Huang CH, Wu TH et al (2022) CREB/Sp1-mediated MCL1 expression and NFκB-mediated ABCB1 expression modulate the cytotoxicity of daunorubicin in chronic myeloid leukemia cells. Toxicol Appl Pharmacol 435:115847

Article  PubMed  CAS  Google Scholar 

Chu X, Zhong L, Dan W et al (2022) DNMT3A R882H mutation drives daunorubicin resistance in acute myeloid leukemia via regulating NRF2/NQO1 pathway. Cell Commun Signal 20:168

Article  PubMed  PubMed Central  CAS  Google Scholar 

Cilibrasi V, Spanò V, Bortolozzi R et al (2022) Synthesis of 2H-Imidazo[2’,1’:2,3] [1,3]thiazolo[4,5-e]isoindol-8-yl-phenylureas with promising therapeutic features for the treatment of acute myeloid leukemia (AML) with FLT3/ITD mutations. Eur J Med Chem 235:114292

Article  PubMed  CAS  Google Scholar 

Collins DM, Bossenmaier B, Kollmorgen G et al (2019) Acquired resistance to antibody-drug conjugates. Cancers (Basel) 11:394

Article  PubMed  CAS  Google Scholar 

Deng W, Chao R, Zhu S (2023) Emerging roles of circRNAs in leukemia and the clinical prospects: an update. Immun Inflamm Dis 11:e725

Article  PubMed  CAS  Google Scholar 

Desikan H, Kaur A, Pogozheva ID et al (2023) Effects of calreticulin mutations on cell transformation and immunity. J Cell Mol Med 27:1032–1044

Article  PubMed  PubMed Central  CAS  Google Scholar 

Dong J, Qin Z, Zhang WD et al (2020) Medicinal chemistry strategies to discover P-glycoprotein inhibitors: An update. Drug Resist Updat 49:100681

Article  PubMed  Google Scholar 

Feng K, Liu J, Wei P et al (2020) lincRNA_Tc13743.2-miR-133–5p-TcGSTm02 regulation pathway mediates cyflumetofen resistance in Tetranychus cinnabarinus. Insect Biochem Mol Biol 123:103413

Article  PubMed  CAS  Google Scholar 

Gómez-Benito M, Conchillo A, García MA et al (2010) EVI1 controls proliferation in acute myeloid leukaemia through modulation of miR-1-2. Br J Cancer 103:1292–1296

Article  PubMed  PubMed Central  Google Scholar 

Isobe T, Takagi M, Sato-Otsubo A et al (2022) Multi-omics analysis defines highly refractory RAS burdened immature subgroup of infant acute lymphoblastic leukemia. Nat Commun 13:4501

Article  PubMed  PubMed Central  CAS  Google Scholar 

Karvonen U, Jääskeläinen T, Rytinki M et al (2008) ZNF451 is a novel PML body- and SUMO-associated transcriptional coregulator. J Mol Biol 382:585–600

Article  PubMed  CAS  Google Scholar 

Kong F, He H, Bai H et al (2022) A biomimetic nanocomposite with enzyme-like activities and CXCR4 antagonism efficiently enhances the therapeutic efficacy of acute myeloid leukemia. Bioact Mater 18:526–538

PubMed  PubMed Central  CAS  Google Scholar 

Kunadt D, Dransfeld C, Dill C et al (2020) Multidrug-related protein 1 (MRP1) polymorphisms rs129081, rs212090, and rs212091 predict survival in normal karyotype acute myeloid leukemia. Ann Hematol 99:2173–2180

Article  PubMed  PubMed Central  CAS  Google Scholar 

Kyriakou TC, Papageorgis P, Christodoulou MI (2021) Common genetic aberrations associated with metabolic interferences in human Type-2 diabetes and acute myeloid leukemia: a bioinformatics approach. Int J Mol Sci. 22:9322

Article  PubMed  PubMed Central  CAS  Google Scholar 

Labbozzetta M, Barreca M, Spanò V et al (2022) Novel insights on [1, 2]oxazolo[5, 4-e]isoindoles on multidrug resistant acute myeloid leukemia cell line. Drug Dev Res 83:1331–1341

Article  PubMed  PubMed Central  CAS  Google Scholar 

Li W, Zhong Y, Shuang Y et al (2017) High concentration of miR-133 is a useful marker for the diagnosis of lymphoma- associated hemophagocytic syndrome. Cancer Biomark 20:159–164

Article  PubMed  CAS  Google Scholar 

Liu G, Li YI, Gao X (2016) Overexpression of microRNA-133b sensitizes non-small cell lung cancer cells to irradiation through the inhibition of glycolysis. Oncol Lett 11:2903–2908

Article  PubMed  PubMed Central  CAS  Google Scholar 

Liu Y, Zhang X, Zhang Y et al (2020) Corrigendum to “Identification of miRNomes in human stomach and gastric carcinoma reveals miR-133b/a-3p as therapeutic target for gastric cancer” [Canc. Lett. 369 (2015) 58–66]. Cancer Lett 494:3–4

Article  PubMed  CAS  Google Scholar 

Liu B, Ma H, Liu Q et al (2023) Correction: MiR-29b/Sp1/FUT4 axis modulates the malignancy of leukemia stem cells by regulating fucosylation via Wnt/β-catenin pathway in acute myeloid leukemia. J Exp Clin Cancer Res 42:208

Article  PubMed  PubMed Central  Google Scholar 

Lv M, Zhang X, Jia H et al (2012) An oncogenic role of miR-142-3p in human T-cell acute lymphoblastic leukemia (T-ALL) by targeting glucocorticoid receptor-α and cAMP/PKA pathways. Leukemia 26:769–777

Article  PubMed  CAS  Google Scholar 

Qian Y, Zhang X, Mao S et al (2023) ACC010, a novel BRD4 inhibitor, synergized with homoharringtonine in acute myeloid leukemia with FLT3-ITD. Mol Oncol 17:1402–1418

Article  PubMed  PubMed Central  CAS  Google Scholar 

Reddy MM, Fernandes MS, Salgia R et al (2011) NADPH oxidases regulate cell growth and migration in myeloid cells transformed by oncogenic tyrosine kinases. Leukemia 25:281–289

Article  PubMed  CAS